All Stories

  1. Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence: supporting the next generation of autophagy researchers and fostering international collaborations

    Article • Autophagy, June 2018, Taylor & Francis

    Dr P Bernard Fourie, Maria Vaccaro, Daniel Klionsky, Prof. Guido Kroemer

  2. Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates

    Article • Journal of Clinical Microbiology, March 2018, ASM Journals

    John Osei Sekyere, Dr P Bernard Fourie

  3. Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates

    Article • Journal of Clinical Microbiology, September 2015, ASM Journals

    Dr P Bernard Fourie

  4. Effects of clofazimine on planktonic and biofilm growth of Mycobacterium tuberculosis and Mycobacterium smegmatis

    Article • Journal of Global Antimicrobial Resistance, March 2015, Elsevier

    Dr P Bernard Fourie

  5. Novel licensure pathways for expeditious introduction of new tuberculosis vaccines: A discussion of the adaptive licensure concept

    Article • Tuberculosis, March 2014, Elsevier

    Dr P Bernard Fourie

  6. Next-Generation Sequencing for Identifying Pyrazinamide Resistance in Mycobacterium tuberculosis

    Article • Clinical Infectious Diseases, December 2013, Oxford University Press (OUP)

    Dr P Bernard Fourie

  7. Dry Powder Antibiotic Aerosol Product Development: Inhaled Therapy for Tuberculosis

    Article • Journal of Pharmaceutical Sciences, November 2013, Elsevier

    Dr P Bernard Fourie

  8. Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media

    Article • Journal of Antimicrobial Chemotherapy, September 2013, Oxford University Press (OUP)

    Dr P Bernard Fourie

  9. Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, March 2013, ASM Journals

    Dr P Bernard Fourie

  10. “Proof-Of-Concept” Evaluation of an Automated Sputum Smear Microscopy System for Tuberculosis Diagnosis

    Article • PLoS ONE, November 2012, PLOS

    Dr P Bernard Fourie

  11. Inhaled Microparticles Containing Clofazimine Are Efficacious in Treatment of Experimental Tuberculosis in Mice

    Article • Antimicrobial Agents and Chemotherapy, November 2012, ASM Journals

    Dr P Bernard Fourie

  12. Characterization of Radiolabeled Dry Powder Leucine, a Constituent of Inhalable Capreomycin

    Article • Drug Delivery Letters, October 2012, Bentham Science Publishers

    Dr P Bernard Fourie

  13. Next-Generation Ion Torrent Sequencing of Drug Resistance Mutations in Mycobacterium tuberculosis Strains

    Article • Journal of Clinical Microbiology, September 2012, ASM Journals

    Dr P Bernard Fourie

  14. Clinical trials of TB vaccines: Harmonization and cooperation

    Article • Tuberculosis, March 2012, Elsevier

    Dr P Bernard Fourie

  15. Inhaled drug therapy for treatment of tuberculosis

    Article • Tuberculosis, January 2011, Elsevier

    Dr P Bernard Fourie

  16. Application of Stepwise Binary Decision Classification for Reduction of False Positives in Tuberculosis Detection from Smeared Slides

    Article • January 2011, ACTA Press

    Dr P Bernard Fourie

  17. The near future: Improving the activity of rifamycins and pyrazinamide

    Article • Tuberculosis, May 2010, Elsevier

    Dr P Bernard Fourie

  18. High Diversity of Mycobacterium tuberculosis Genotypes in South Africa and Preponderance of Mixed Infections among ST53 Isolates

    Article • Journal of Clinical Microbiology, April 2009, ASM Journals

    Dr P Bernard Fourie

  19. Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis Isolates

    Article • Journal of Clinical Microbiology, August 2008, ASM Journals

    Dr P Bernard Fourie

  20. Acquired rifamycin resistance: pharmacology and biology

    Article • Expert Review of Anti-infective Therapy, April 2008, Taylor & Francis

    Dr P Bernard Fourie

  21. Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase

    Article • Bioorganic & Medicinal Chemistry, December 2007, Elsevier

    Dr P Bernard Fourie

  22. Inhaled Large Porous Particles of Capreomycin for Treatment of Tuberculosis in a Guinea Pig Model

    Article • Antimicrobial Agents and Chemotherapy, May 2007, ASM Journals

    Dr P Bernard Fourie

  23. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis

    Article • Phytomedicine, November 2006, Elsevier

    Dr P Bernard Fourie

  24. The Early Bactericidal Activities of Rifampin and Rifapentine in Pulmonary Tuberculosis

    Article • American Journal of Respiratory and Critical Care Medicine, July 2005, American Thoracic Society

    Dr P Bernard Fourie

  25. Prospects for new tuberculosis treatment in Africa

    Article • Tropical Medicine & International Health, July 2004, Wiley

    Dr P Bernard Fourie

  26. Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective

    Article • Methods and Findings in Experimental and Clinical Pharmacology, January 2004, Prous Science

    Dr P Bernard Fourie

  27. Fixed-Dose Combination Drugs for Tuberculosis

    Article • Drugs, January 2003, Springer Science + Business Media

    Dr P Bernard Fourie

  28. Whither Mycobacterium vaccae—encore

    Article • The Lancet, October 2002, Elsevier

    Dr P Bernard Fourie

  29. Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis.

    Article • American Journal of Respiratory and Critical Care Medicine, November 1996, American Thoracic Society

    Dr P Bernard Fourie

  30. Respiratory tuberculosis in childhood

    Article • The Pediatric Infectious Disease Journal, March 1995, Wolters Kluwer Health

    Dr P Bernard Fourie

  31. The use of a killed Mycobacterium vaccae preparation in clinical tuberculosis; a major trial in South Africa

    Article • Tubercle and Lung Disease, June 1994, Elsevier

    Dr P Bernard Fourie

  32. Childhood tuberculosis and tuberculous meningitis: high incidence rates in the Western Cape of South Africa

    Article • Tubercle and Lung Disease, December 1992, Elsevier

    Dr P Bernard Fourie

  33. The use of cefadroxil in superinfected atopic dermatitis

    Article • Current Therapeutic Research, November 1992, Elsevier

    Dr P Bernard Fourie

  34. Mycobacterium tuberculosis in a closed colony of baboons (Papio ursinus)

    Article • Laboratory Animals, April 1983, SAGE Publications

    Dr P Bernard Fourie

  35. Follow-up tuberculosis prevalence survey of Transkei

    Article • Tubercle, June 1980, Elsevier

    Dr P Bernard Fourie